Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 570-575

  Scarpino, Stefania ^a   Stoppacciaro, Antonella ^a   Colarossi, Cristina ^a   Cancellario, Francesca ^a   Marzullo, Antonella ^a   Marchesi, Maurizio ^a   Biffoni, Marco ^a   Comoglio, Paolo M ^b   Prat, Maria ^b,d   Ruco, Luigi P ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Dipto di Medicina Sperimentale   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

HGF; Invasiveness; Met; Papillary carcinoma; Thyroid tumours

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID PAPILLARY CARCINOMA;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL DIVISION; COCULTURE TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HUMANS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; STIMULATION, CHEMICAL; THYROID GLAND; THYROID NEOPLASMS;

EID: 0032740967     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<570::AID-PATH470>3.0.CO;2-3     Document Type: Article

References (37)

1. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989; 339: 155-156.
2. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude GF. Sequence of MET protooncogene cDNA has features characteristic of the thyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci U S A 1987; 84: 6379-6383.
3. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804.
4. Naldini L, Vigna E, Narsimhan R, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogene 1991; 6: 501-504.
5. Naldini L, Weidner KM, Vigna E, et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991; 10: 2867-2878.
6. Prat M, Narsimhan R, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991; 49: 323-328.
7. Rosen EM, Nigam SK, Goldberg I. Scatter factor and c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 1994; 127: 1783-1787.
8. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-1180.
9. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature 1987; 327: 239-242.
10. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: molecular characteristics and effect on invasiveness of epithelial cells. J Cell Biol 1990; 111: 2097-2108.
11. Dignass AU, Lynch-Devaney K, Podolsky DK. Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 1994; 202: 701-709.
12. Di Renzo MF, Olivero M, Ferro S, et al. Overexpression of the c-met/hgf receptor gene in human thyroid carcinomas. Oncogene 1992; 7: 2549-2553.
13. Ruco LP, Ranalli T, Marzullo A, et al. Expression of Met protein in thyroid tumours. J Pathol 1996; 180: 266-270.
14. Zanetti A, Stoppacciaro A, Marzullo A, et al. Expression of Met-protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. J Pathol 1998; 186: 287-291.
15. Filetti S, Rapoport B. Autoregulation by iodine of thyroid protein synthesis: influence of iodine on amino acid transport in cultured thyroid cells. Endocrinology 1984; 114: 1379-1385.
16. Prat M, Crepaldi T, Gandino L, Giodano S, Longati P, Comoglio PM. C-terminal truncated forms of Met, the hepatocyte growth factor receptor. Mol Cell Biol 1991; 11: 5954-5962.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
18. Naldini L, Vigna E, Bardelli A, Follenzi A, Gulimi F, Comoglio PM. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem 1995; 270: 603-611.
19. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-3245.
20. Prat M, Crepaldi T, Pennacchietti S, Bussolino F, Comoglio PM. Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. J Cell Sci 1998; 111: 237-247.
21. Crepaldi T, Pollack AL, Prat M, Zborek A, Mostov K, Comoglio PM. Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells. J Cell Biol 1994; 125: 313-320.
22. Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinoma. Nature Genet 1997; 16: 68-73.
23. Di Renzo MF, Olivero M, Giacomini A, et al. Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147-154.
24. Maggiora P, Gambarotta G, Olivero M, Giordano S, Di Renzo MF, Comoglio MP. Control of invasive growth by the HGF receptor family. J Cell Physiol 1997; 173: 183-186.
25. Ivan M, Bond JA, Prat M, Comoglio PM, Wynford-Thomas D. Activated ras and ret oncogenes induce overexpression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene 1997; 14: 2417-2423.
26. Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signalling and transformation by the hepatocyte growth factor/ scatter factor receptor family. Cell 1994; 77: 261-271.
27. Giordano S, Bardelli A, Zhen Z, Menard S, Ponzetto C, Comoglio PM. A point mutation in the MET oncogene abrogates metastasis without affecting transformation. Proc Natl Acad Sci U SA 1997; 94: 13868-13872.
28. Naldini L, Tamagnone L, Vigna E, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992; 11: 4825-4833.
29. Blasi F. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? Immunol Today 1997; 18: 415-417.
30. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9: 714-724.
31. Dremier S, Taton M, Coulonval K, Nakamura T, Matsumoto K, Dumont JE. Mitogenic, dedifferentiating, and scattering effects of hepatocyte growth factor on dog thyroid cells. Endocrinology 1994; 135: 135-140.
32. Eccles N, Ivan M, Wynford-Thomas D. Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor. Mol Cell Endocrinol 1996; 117: 247-251.
33. Li H, Shimura H, Aoki Y, et al. Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro. Clin Exp Metastasis 1998; 16: 74-82.
34. Paciucci R, Vila MR, Adell T, et al. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met. Am J Pathol 1998; 153: 201-212.
35. Katoh R, Bray CE, Suzuki K, et al. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol 1995; 26: 139-146.
36. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985; 55: 805-828.
37. Rosai J, Carcangiu ML, De Lellis LA. Atlas of Tumor Pathology. Tumors of the Thyroid Gland. Armed Forces Institute of Pathology: Washington, DC, 1992.